GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q2M Biotech AG (HAM:QBI) » Definitions » Current Deferred Revenue

Q2M Biotech AG (HAM:QBI) Current Deferred Revenue : €0.00 Mil (As of . 20)


View and export this data going back to 2011. Start your Free Trial

What is Q2M Biotech AG Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Q2M Biotech AG's current deferred revenue for the quarter that ended in . 20 was €0.00 Mil.

Q2M Biotech AG Current Deferred Revenue Historical Data

The historical data trend for Q2M Biotech AG's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q2M Biotech AG Current Deferred Revenue Chart

Q2M Biotech AG Annual Data
Trend
Current Deferred Revenue

Q2M Biotech AG Quarterly Data
Current Deferred Revenue

Q2M Biotech AG Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Q2M Biotech AG's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Q2M Biotech AG (HAM:QBI) Business Description

Traded in Other Exchanges
N/A
Address
Haeschenstrasse 17-19, Bremen, DEU
Website
Q2M Biotech AG is a biotechnology company that examines and explains genetic information. The Company is also involved in the creation, development and sale of products, systems and solutions in the biotechnology field.

Q2M Biotech AG (HAM:QBI) Headlines

No Headlines